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Prevalence of Escherichia coli Carriage in the
Oropharynx of Ambulatory Children and Adults with
and without Upper Respiratory Symptoms
To the Editor:
Escherichia coli is a common gut commensal and an important
human pathogen that rarely causes pneumonia in the
community. However, E. coli increasingly causes hospital-
acquired pneumonia, particularly among intensive care unit (ICU)
patients (1, 2). E. coli pneumonia, similar to other hospital-
acquired and ventilator-associated pneumonias, is responsible for
longer ICU and hospital stays, high morbidity and mortality,
and increased antibiotic consumption and hospital costs (1, 2).
This is particularly true since the recent global emergence
and spread of E. coli strains producing extended-spectrum
b-lactamases, which constitute a major public health concern (3).
E. coli identified in protected bronchoalveolar lavage
specimens from ICU patients with ventilator-acquired pneumonia
is often genetically identical to the strains found in their dental
plaque and oropharyngeal cavity (4, 5). Yet little is known about
oropharyngeal colonization by E. coli, with most studies dating
back 30 years ago (6–9). Because no recent work has addressed
E. coli carriage in the community, we aimed to fill this gap in
the literature by estimating the E. coli carriage rates among
otherwise healthy adults and children with and without upper
respiratory symptoms. We detected E. coli using quantitative PCR
(qPCR), which is more sensitive than culture.
Methods
Using a collection of oropharyngeal samples from participants in
two community cohort studies ongoing in Southeast Michigan
during the 2012–2013 and 2013–2014 influenza season, the
Household Influenza Vaccination Effectiveness Study (HIVE) (10)
and the eX-FLU study (11), we estimated the prevalence of E. coli
oropharyngeal carriage among 589 subjects. HIVE participants
(range, 2–70 yr old) were recruited among households with at least
two children (for details, see Reference 10). eX-FLU participants
were college students (aged 18–21 yr; mean, 19.2 yr) living in
dormitories and enrolled using a social network referral model.
Students suffering from upper respiratory symptoms defined as
cough and fever/feverishness, body aches, or chills (cough plus one
of fever/feverishness, chills, or body aches) were requested to
provide samples at onset. Their healthy social contacts (no illness
in the previous 14 d) were also sampled.
We used a highly sensitive qPCR assay for E. coli detection,
as bacterial load was anticipated to be lower than among
hospitalized patients. We limited our analysis to oropharyngeal
swabs collected from 152 adults and 186 children from the HIVE
study at the time of acute respiratory illness (an illness ,7 d
duration with cough, fever or feverishness, nasal congestion, chills,
headache, body aches, or sore throat) and to 251 college students
from the eX-FLU study, 130 of whom (52%) had upper respiratory
symptoms and 121 of whom were the healthy contacts.
Dual throat swabs were collected from participants and
conserved in universal transport media and in sterilized skim milk
at 2808C. After bacterial DNA extraction from the universal
media sample, qPCR was performed using primers specific to
the 16S ribosomal genes in E. coli previously designed by our
laboratory (12). All assays were conducted in triplicate. A
no-template control and E. coli MG1655 positive control were
included in every run. Negative samples were those with cycle
threshold (CT) values higher than 40. E. coli MG1655 was used to
determine the accurate limit of detection of qPCR by comparing
cultures on MacConkey agar with qPCR results for sequential
dilutions starting with a Macfarlane 5 dilution. In parallel, we
cultured on MacConkey agar a subset of skim milk specimens
both from subjects with qPCR results of more than 104 genomic
copies/mL and from E. coli-negative subjects.
Results
Altogether, 21/338 (6.2%) HIVE and 20/251 (7.9%) eX-FLU
participants carried E. coli, using a detection limit of 103 genomic
copies/mL (P = 0.4) (Table 1). Mean bacterial load for positive
samples was 4.3 Log genomic copies/mL (SD, 0.32), with
a maximum of 5.7 Log genomic copies/mL. Using sequential
dilutions of the MG1655 strain, we estimated the limit of detection
by culture to be approximately 105 genomic copies/mL of skim
milk, which is two Logs higher than the qPCR assay. None of the
skim milk samples grew E. coli on MacConkey agar. No difference
was found either in carriage rates or relative abundance of E. coli
among positive samples between adults and children, by age
group in the HIVE cohort, or between subjects with and without
acute upper respiratory symptoms in the eX-FLU study.
Discussion
In two different large cohorts of ambulatory children and adults
with and without acute respiratory symptoms, we found that
carriage of E. coli in the throat was a rare event, despite use of
a highly sensitive detection method. E. coli carriage did not
differ by age, age group, or the existence of upper respiratory
symptoms. Relative bacterial loads were low and unaffected either
by age or upper respiratory symptoms.
Our findings are similar to those of previous studies of subjects
from the community (6, 8, 9). A study conducted among 250
individuals in Texas published in 1969 found an increased
prevalence in oropharyngeal carriage of gram-negative bacteria
by severity of illness, from 2% in healthy subjects to 57% in
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“moribund” patients (9). A 1994 study following 114 healthy
infants from birth to 2 years detected, using culture, a prevalence
of E. coli throat carriage ranging from 0% to 13% (13). The
prevalence of gram-negative rods in a 1975 study among 100
healthy individuals aged 3–70 years (mean age, 43 years) who did
not take antibiotics in the previous year was 17% (14).
Although our study population was weighted heavily toward
children and young adults, our sample did include 63 adults aged
41–70 years. In this largest cohort of older adults assessed to
date, the prevalence of oropharyngeal carriage of E. coli was 4.8%
(3/63). This older population is more likely to have chronic
illnesses and be hospitalized in an adult ICU. In addition, others
have found higher rates of E. coli carriage in hospitalized children
(including some in ICU) than in the community (6). The large
age span covered by our population of subjects confirms previous
findings that E. coli colonization is rare in ambulatory subjects.
Carriage rates of E. coli in the oropharynx of patients in the
ICU are far greater (even as detected using culture) than those
observed in the community (9, 15, 16). More severely ill ICU
patients, and those with diabetes or alcoholism (7, 9), are at greater
risk for colonization with gram-negative bacteria, especially if their
treatment includes mechanical ventilation (15). Further, a study
published in 1994 found that patients colonized with gram-
negative bacteria (including E. coli) were more likely to develop
gram-negative bacterial pneumonia during their ICU stay (15). In
2012, 132 French ICU patients were screened for E. coli using
culture: 37 (28.0%) were colonized in their oropharynx, 13 also
had lung colonization, and 12 patients had both lung colonization
and clinical E. coli pneumonia (16). Others have shown
that colonization by E. coli occurs in the first 4 days after
hospitalization (15). Therefore, a major shift in E. coli carriage
seems to occur upon admission to an ICU. This probably explains
why ICU patients are at higher risk of developing E. coli
pneumonia.
We hypothesize that E. coli oropharyngeal colonization is
a multifactorial process promoted by prolonged supine position,
inhalation from the stomach, modified gastric pH resulting from
the common use of proton inhibitors, and multiple interactions
with healthcare workers and/or potentially from some disturbed
local immunity. These factors may explain why such low rates
of E. coli are found in the oropharynx of ambulatory subjects
compared with those found in ICU patients, in turn explaining
the increased risk for E. coli pneumonia in ICU subjects, as
colonization appears to precede inhalation in the lungs (15, 16).
One report suggests that E. coli colonizing the oropharynx and
subsequently responsible for ventilator-associated pneumonia
originates from the subjects’ own gut (16). Further studies are
needed to determine the dynamics of and risk factors for
E. coli colonization of the oropharynx and how frequently
oropharyngeal and intestinal E. coli are identical to determine
effective prevention and control strategies among ICU patients.
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financial support.
Victoire de Lastours, M.D., Ph.D.
Ryan E. Malosh, M.P.H.
University of Michigan School of Public Health
Michigan
Allison E. Aiello, Ph.D.
University of North Carolina Gillings School of Global Public Health
North Carolina
Betsy Foxman, Ph.D.
University of Michigan School of Public Health
Michigan
References
1 Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir
Crit Care Med 2002;165:867–903.
2 Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno
R, Lipman J, Gomersall C, Sakr Y, et al.; EPIC II Group of
Investigators. International study of the prevalence and outcomes of
infection in intensive care units. JAMA 2009;302:2323–2329.
3 Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM,
Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, et al.
CTX-M: changing the face of ESBLs in Europe. J Antimicrob
Chemother 2007;59:165–174.
4 Heo S-M, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. Genetic
relationships between respiratory pathogens isolated from dental
plaque and bronchoalveolar lavage fluid from patients in the
intensive care unit undergoing mechanical ventilation. Clin Infect Dis
2008;47:1562–1570.
Table 1. Oropharyngeal carriage of Escherichia coli in subjects
from the community in southeast Michigan participating in the
Household Influenza Vaccine Effectiveness Study (participants
in a household study with acute respiratory illness during
2013–2014 influenza season) and the eX-FLU study (college
students with upper respiratory symptoms and their healthy













2–3 20 2 (10)
4–6 74 5 (6.8)
7–15 92 7 (7.6)
21–30 8 0
31–40 81 4 (4.9)
41–50 56 3 (5.4)
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Healthy contact 121 10 (8.3)
All 251 20 (7.9)
Escherichia coli was detected using quantitative polymerase chain
reaction.
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